profit from every $100 of sales.
$0$100
Amdocs
$41.46-0.67% today
-51.5% in 1 year
1-year low $41.461-year high $85.49
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $7.67 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Amdocs sold, what it kept, and what it did with the cash.
Sales went from $4.58 billion in 2022 to $4.53 billion in 2025, with $565 million of profit last year.
SalesProfit
Amdocs handed back more cash to shareholders than it generated last year.
Buybacks $551M$224M
Free cash flow 2025$645M
Bought back its own shares$551M
Paid as dividends$224M
Cash vs. debt$325M vs. $826M
Amdocs vs. similar companies
Amdocs grows the slowest of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Amdocs | 7.7× · Cheap | ||
 Microsoft | 29.6× · Fair price | ||
 Palantir Technologies | 250.3× · Very expensive | ||
 Oracle | 21.5× · Fair price | ||
 Palo Alto Networks | 235.6× · Very expensive |
AI analysis
An AI analyst reads Amdocs's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 4,577 | 4,888 | 5,005 | 4,533 | |
| 1,619 | 1,728 | 1,755 | 1,722 | |
| 665 | 725 | 760 | 812 | |
| 890 | 857 | 821 | 931 | |
| 550 | 541 | 493 | 565 | |
| 4.44 | 4.49 | 4.25 | 5.05 | |
| 35.4% | 35.3% | 35.1% | 38.0% | |
| 14.5% | 14.8% | 15.2% | 17.9% | |
| 12.0% | 11.1% | 9.9% | 12.5% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 6,390 | 6,426 | 6,386 | 6,250 |
| Cash | 573 | 520 | 346 | 325 |
| Total debt | 827 | 807 | 790 | 826 |
| Total liabilities | 2,830 | 2,859 | 2,887 | 2,779 |
| 3,518 | 3,524 | 3,457 | 3,429 | |
| 124 | 121 | 116 | 112 | |
| 12.1% | 12.0% | 11.6% | 13.7% | |
| 15.6% | 15.3% | 14.3% | 16.5% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 757 | 823 | 724 | 749 | |
| 227 | 124 | 105 | 104 | |
| 530 | 698 | 619 | 645 | |
| Dividends paid | 186 | 199 | 212 | 224 |
| 508 | 490 | 563 | 551 | |
| 72 | 90 | 105 | 105 |
Valuation
- 7.7×
- 5.6×
- 1.75
- 1.9×
- 1.0×
- 6.7×
- 5.2×
- 14.9%
- 13.0%
- 3.5%
Profitability
- 38.0%
- 17.9%
- 12.5%
- 20.6%
- 12.7%
- 13.1%
- 15.9%
- 8.6%
- 16.8%
- 7.4%
Growth
- −0.3%
- +4.4%
- +4.2%
- +10.0%
- −3.3%
Financial health
- 0.9×
- 0.32
- 16.8%
- 27.4×
- 0.98
- 0.98
- 0.73
How it ranks in Technology
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 28%of 966
Top 24%of 973
Top 3%of 723
Bottom 19%of 980
Top 4%of 979
What analysts expect
- Average price target
- $90.00
- Range
- $88.00 – $92.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 13, 2026 | 1.78 | 1.77 | +0.6% |
| Feb 3, 2026 | 1.81 | 1.75 | +3.4% |
| Nov 11, 2025 | 1.83 | 1.82 | +0.5% |
| Aug 6, 2025 | 1.72 | 1.71 | +0.6% |
| May 7, 2025 | 1.78 | 1.71 | +4.1% |
| Feb 4, 2025 | 1.66 | 1.64 | +1.2% |
| Nov 12, 2024 | 1.70 | 1.70 | +0.0% |
| Aug 7, 2024 | 1.62 | 1.60 | +1.3% |
3.5%of the share price, paid each year
On $1,000 invested$35a year at today's yield, before tax
+10.0%2020 to 2025
Raised10 yearsin a row, in our data
Paid per share, each year
$0.68 in 2015 → $2.11 in 2025
How safe it looks
39.7% of its profit
Room to growStretchedMore than it earns: 34.8%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
3/7Passes 3 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
70Pass
Benjamin Graham
72Pass
Philip Fisher
58No pass
Peter Lynch
38No pass
Joel Greenblatt
62Pass
Charlie Munger
56No pass
Terry Smith
47No pass
Questions about Amdocs
Is Amdocs a good stock to buy?
A solid business, and the price looks low. 3 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Amdocs AI analysis
What does Amdocs do?
Amdocs Limited, through its subsidiaries, provides software and services worldwide. The company designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. It is in Software - Infrastructure, based in Saint Louis, MO, United States, with 26,969 employees.
Does Amdocs pay a dividend?
Yes. At today's price the dividend is 3.5% a year, about 40% of its yearly profit. In 2025 it paid out $224 million in dividends.
Is Amdocs stock halal?
Yes. Amdocs passes our halal screen: its business is permitted and its debt is 19% of its market value, under the 30% limit. How we check
How has Amdocs stock done over the past year?
Down 51.5% over the past twelve months, to $41.46. It traded between $41.46 and $85.49 and is 51.5% below its high.
Who are Amdocs's competitors?
The largest listed companies in the same industry are Microsoft, Palantir Technologies, Oracle and Palo Alto Networks. The peers table on this page compares their profit, growth and price with Amdocs's.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.